Pauline Brice
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 162
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 45
- Oncology top 0.2%
- Viral-associated cancers and disorders 61
- CAR-T cell therapy research 11
- Neurology top 0.5%
- CNS Lymphoma Diagnosis and Treatment 35
- Reproductive Medicine top 1%
-
- Lung Cancer Treatments and Mutations 42
-
- Cutaneous lymphoproliferative disorders research 15
-
- Immune Cell Function and Interaction 11
- Co-authors
- Corinne HaïounÉric LepageHervé TillyBertrand CoiffierNicole BrousseGilles SallesChristian GisselbrechtY Bastion
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Pauline Brice
185 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Pathology and Forensic Medicine 6.3k
- Genetics 2.0k
- Oncology 5.0k
- Neurology 2.1k
- Reproductive Medicine 579
Countries citing papers authored by Pauline Brice
This map shows the geographic impact of Pauline Brice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pauline Brice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pauline Brice more than expected).
Fields of papers citing papers by Pauline Brice
This network shows the impact of papers produced by Pauline Brice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pauline Brice. The network helps show where Pauline Brice may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pauline Brice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 18 | |
| 3 | 2023 | 39 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 1 | |
| 7 | 2018 | 7 | |
| 8 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphomabreakdown → | 2017 | 694 |
| 9 | 2013 | 4 | |
| 10 | 2012 | 82 | |
| 11 | 2012 | 188 | |
| 12 | Impact of induction chemotherapy regimen on response, safety and outcome in the PRIMA study | 2011 | 12 |
| 13 | 2008 | 239 | |
| 14 | 2008 | 90 | |
| 15 | 2008 | 97 | |
| 16 | 2008 | 25 | |
| 17 | 2006 | 162 | |
| 18 | 1996 | 3 | |
| 19 | 1996 | 56 | |
| 20 | Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. | 1992 | 22 |
About Pauline Brice
Pauline Brice is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 192 papers that have together received 8.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (162 papers), Viral-associated cancers and disorders (61 papers), Chronic Lymphocytic Leukemia Research (45 papers), Lung Cancer Treatments and Mutations (42 papers), CNS Lymphoma Diagnosis and Treatment (35 papers), Cutaneous lymphoproliferative disorders research (15 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.3k citations), Genetics (2.0k citations) and Oncology (5.0k citations). Pauline Brice has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Corinne Haïoun, Éric Lepage, Hervé Tilly, Bertrand Coiffier, Nicole Brousse, Gilles Salles, Christian Gisselbrecht, Y Bastion, Philippe Solal‐Céligny and Josette Brière. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Cancer and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.